Mass Cytometry Reveals Single-cell Kinetics Of Cytotoxic Lymphocyte Evolution In Cmv-infected Renal Transplant Patients
1UCSF, San Francisco, CA, 2Univ of California LA, Los Angeles, CA, 3University of California San Francisco, San Francisco, CA
Meeting: 2022 American Transplant Congress
Abstract number: 924
Keywords: Cytomeglovirus
Topic: Basic Science » Basic Science » 07 - Vascular, Lymphatic, Stromal and Parenchymal Cell Biology
Session Information
Session Name: Vascular, Lymphatic, Stromal and Parenchymal Cell Biology
Session Type: Poster Abstract
Date: Sunday, June 5, 2022
Session Time: 7:00pm-8:00pm
Presentation Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
*Purpose: Cytomegalovirus (CMV) infection is associated with graft rejection in renal transplantation. Memory-like NK cells expressing NKG2C and lacking FcεRIγ are established during CMV infection.
*Methods: Here, we interrogated the in vivo kinetics of lymphocytes in CMV-infected renal transplant patients using longitudinal samples, compared with non-viremic (NV) patients. Recipient CMV seropositive (R+) patients had pre-existing memory-like NK cells (NKG2C+CD57+FcεRIγ–) at baseline, which decreased in the periphery immediately after transplantation in both viremic and NV patients.
*Results: We identified a novel subset of pre-memory-like NK cells (NKG2C+CD57+FcεRIγlow-dim) that increased during viremia in R+ viremic patients. These cells showed a higher cytotoxic profile than pre-existing memory-like NK cells with transient upregulation of FcεRIγ and Ki67 expression at the acute phase, with the subsequent accumulation of new memory-like NK cells at later phases of viremia. Furthermore, cytotoxic NKG2C+CD8+ T cells and cytotoxic γδ T cells significantly increased in viremic patients and these three different cytotoxic cells combinatorically responded to viremia.
*Conclusions: All viremic patients, except one, overcame viremia and didn’t experience graft rejection. These data provide new insights into in vivo dynamics and interplay of cytotoxic lymphocytes responding to CMV viremia, which are potentially linked with control of CMV viremia to prevent graft rejection.
To cite this abstract in AMA style:
Ishiyama K, Arakawa-Hoyt J, Aguilar O, Sigdel T, Tamaki S, Babdor J, Spitzer M, Reed E, Sarwal M, Lanier L. Mass Cytometry Reveals Single-cell Kinetics Of Cytotoxic Lymphocyte Evolution In Cmv-infected Renal Transplant Patients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/mass-cytometry-reveals-single-cell-kinetics-of-cytotoxic-lymphocyte-evolution-in-cmv-infected-renal-transplant-patients/. Accessed November 21, 2024.« Back to 2022 American Transplant Congress